BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications
Publications
  •   Lower Irisin Level in Patients with Type 2 Diabetes Mellitus: a Case-control Study and Meta-analysis. Zhang, C., Z. Ding, G. Lv, J. Li, P. Zhou and J. Zhang. J Diabetes. 2014.
  •   Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Yin, Y., X. Cai, X. Chen, H. Liang, Y. Zhang, J. Li, Z. Wang, X. Chen, W. Zhang, S. Yokoyama, C. Wang, L. Li, L. Li, D. Hou, L. Dong, T. Xu, T. Hiroi, F. Yang, H. Ji, J. Zhang, K. Zen and C. Y. Z
  •   MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. Tu, X., H. Zhang, J. Zhang, S. Zhao, X. Zheng, Z. Zhang, J. Zhu, J. Chen, L. Dong, Y. Zang and J. Zhang. J Pathol. 2014;234(1):46-59.
  •   A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Huang, Z., Z. Wang, S. Long, H. Jiang, J. Chen, J. Zhang and L. Dong. Mol Pharm. 2014;11(7):2051-2061.
  •   miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. Wang, N., H. Liang, Y. Zhou, C. Wang, S. Zhang, Y. Pan, Y. Wang, X. Yan, J. Zhang, C. Y. Zhang, K. Zen, D. Li and X. Chen. PLoS One. 2014;9(8):e105570.
  •   miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\'s disease. Huang, Z., T. Shi, Q. Zhou, S. Shi, R. Zhao, H. Shi, L. Dong, C. Zhang, K. Zeng, J. Chen and J. Zhang. Gut. 2014;63(8):1247-1257.
  •   3,3\'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Zhang, Z., Z. Gao, W. Hu, S. Yin, C. Wang, Y. Zang, J. Chen, J. Zhang and L. Dong. Br J Pharmacol. 2013;170(3):649-660.
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy. Zhu, Q., L. Jia, Z. Gao, C. Wang, H. Jiang, J. Zhang and L. Dong. Mol Pharm. 2014;11(10):3269-3278.
  •   Lower Irisin Level in Patients with Type 2 Diabetes Mellitus: a Case-control Study and Meta-analysis. Zhang, C., Z. Ding, G. Lv, J. Li, P. Zhou and J. Zhang. J Diabetes. 2014.
  •   Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Yin, Y., X. Cai, X. Chen, H. Liang, Y. Zhang, J. Li, Z. Wang, X. Chen, W. Zhang, S. Yokoyama, C. Wang, L. Li, L. Li, D. Hou, L. Dong, T. Xu, T. Hiroi, F. Yang, H. Ji, J. Zhang, K. Zen and C. Y. Z
  •   MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. Tu, X., H. Zhang, J. Zhang, S. Zhao, X. Zheng, Z. Zhang, J. Zhu, J. Chen, L. Dong, Y. Zang and J. Zhang. J Pathol. 2014;234(1):46-59.
  •   A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Huang, Z., Z. Wang, S. Long, H. Jiang, J. Chen, J. Zhang and L. Dong. Mol Pharm. 2014;11(7):2051-2061.
  •   miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. Wang, N., H. Liang, Y. Zhou, C. Wang, S. Zhang, Y. Pan, Y. Wang, X. Yan, J. Zhang, C. Y. Zhang, K. Zen, D. Li and X. Chen. PLoS One. 2014;9(8):e105570.
  •   miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\'s disease. Huang, Z., T. Shi, Q. Zhou, S. Shi, R. Zhao, H. Shi, L. Dong, C. Zhang, K. Zeng, J. Chen and J. Zhang. Gut. 2014;63(8):1247-1257.
  •   3,3\'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Zhang, Z., Z. Gao, W. Hu, S. Yin, C. Wang, Y. Zang, J. Chen, J. Zhang and L. Dong. Br J Pharmacol. 2013;170(3):649-660.
  •   MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review. Zhou, G., X. Shi, J. Zhang, S. Wu and J. Zhao. J Int Med Res. 2013;41(1):1-12.
  •   The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. Zhang, Z., Y. Zha, W. Hu, Z. Huang, Z. Gao, Y. Zang, J. Chen, L. Dong and J. Zhang. J Biol Chem. 2013;288(52):37082-37093.
  •   3,3\\\'-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. Yao, Z., W. Hu, S. Yin, Z. Huang, Q. Zhu, J. Chen, Y. Zang, L. Dong and J. Zhang. Pharmacol Res. 2013;70(1):139-146.
  •   Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Yang, C., C. Wang, X. Chen, S. Chen, Y. Zhang, F. Zhi, J. Wang, L. Li, X. Zhou, N. Li, H. Pan, J. Zhang, K. Zen, C. Y. Zhang and C. Zhang. Int